GlassScriptPhysician profile
David Knudtson
NPI 1558420323
$4,664.81
in general payments reported to CMS, 2019-2025
20 companies · $1,195 in 2025
The $1,195 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $446 · 2022: $1,146 · 2023: $823 · 2024: $1,055 · 2025: $1,195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,072.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $803.76 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $790.80 | 2021-2025 | Jardiance, Synjardy, Tradjenta |
| Pfizer INC. | $770.59 | 2021-2025 | |
| Novo Nordisk INC | $588.66 | 2022-2025 | Rybelsus, Ozempic, Tresiba |
| Amgen INC. | $518.12 | 2022-2025 | Evenity, Prolia, Repatha |
| Glaxosmithkline, LLC. | $207.18 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novartis Pharmaceuticals Corporation | $202.70 | 2024-2025 | |
| Lilly USA, LLC | $195.87 | 2022-2025 | Jardiance, Mounjaro, Zepbound |
| Janssen Pharmaceuticals, INC | $129.12 | 2023-2024 | Xarelto, Spotlight |
| Teleflex LLC | $86.14 | 2024 | Urolift |
| Esperion Therapeutics, INC. | $65.53 | 2024 | Nexletol |
| Merck Sharp & Dohme LLC | $51.08 | 2021-2025 | Capvaxive, Gardasil 9 |
| Biohaven Pharmaceutical Holding Company LTD. | $48.74 | 2022 | |
| Exact Sciences Corporation | $44.28 | 2025 | The Cologuard Plus Collection Kit |
| Kowa Pharmaceuticals America, INC. | $41.54 | 2021-2024 | Livalo |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $31.85 | 2022 | |
| Abc Home Medical Supply, INC. | $30.11 | 2025 | |
| Amarin Pharma, INC. | $24.04 | 2021 | |
| Almatica Pharma LLC | $17.46 | 2023 | Gralise, Loreev Xr, Sertraline Hcl |
| Aimmune Therapeutics, INC. | $17.24 | 2025 | Zenpep |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Knudtson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.